R&D- Medical: Other (Engineering Development)

Code AN94

Child

Spend Category Level 1

Not listed

Spend Category Level 2

Not listed

Parent PSC

PSC AN94 encompasses research and development activities specifically focused on medical engineering development. This category represents specialized scientific and technological investigations aimed at advancing medical technologies through engineering-based approaches. The work typically involves complex prototyping, technical feasibility studies, and experimental design targeting innovative medical solutions that require substantial technical expertise and precision engineering methodologies.

Federal Contract Awards in this PSC category predominantly target advanced medical research initiatives with contract values ranging between $500,000 to $5 million and durations spanning 12-36 months. Primary funding agencies include the Department of Defense, Department of Health and Human Services, and the National Institutes of Health. Contract awards frequently target research institutions, medical technology firms, and specialized engineering laboratories with demonstrated capabilities in medical device development and biomedical engineering. Set-aside contracts often prioritize small businesses with specialized medical engineering capabilities, particularly those owned by disadvantaged or service-disabled veteran entrepreneurs.

No specific federal contract opportunities were provided within the submitted materials for PSC AN94. Without additional context or data, a comprehensive description of current solicitations cannot be constructed. Further investigation would be required to detail current medical engineering development research opportunities being sought by federal agencies.

Generated 10/19/25, 12:09 AM

Name	Awardee	Potential Value	AwardDate	LastDateToOrder	Updated At
DAMD1787C7022	University Of Maryland	$0	2/15/88	Not listed	2/15/88
DAMD1788C8038	Rohm And Haas Company	$0	12/15/87	Not listed	12/15/87
DAMD1781C1115	No Data From D And B	$0	10/15/85	Not listed	10/15/85
200200100112	None	$0	9/15/01	3/15/02	9/15/01
DAAK6085C0046	None	$0	4/15/85	Not listed	4/15/85

Name	Awardee	Potential Value	AwardDate	CompletionDate	Updated At
Definitive Contract MD170199012DDAMD1791C1028	None	$0	12/15/90	Not listed	12/15/90
Purchase Order MD170198810BDAMD1788C8038	None	$0	10/15/88	5/15/90	3/15/95
Purchase Order HHSI161200900011P	Enterprise Staffing Agency LIMITED Liability Company	$8.0k	11/5/08	12/31/10	8/31/10
Purchase Order MD170199509BDAMD1795C5087	Engility Corporation	$0	9/15/95	9/15/96	9/15/96
Other Transaction Agreement W15QKN1790010	Qool Therapeutics, Inc.	$4.1m	3/27/17	3/26/18	3/6/18